Beam Therapeutics Inc. Competitors
Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|---|
CRBU
|
Caribou Biosciences, Inc. | $2.02 | $176.12 M | -1.41 | 158 | $34.48 M |
CRSP
|
CRISPR Therapeutics AG | $47.52 | $4.91 B | -21.43 | 407 | $371.21 M |
DNA
|
Ginkgo Bioworks Holdings, Inc. | $7.22 | $1.14 B | -1.2 | 1218 | $251.46 M |
EDIT
|
Editas Medicine, Inc. | $2.48 | $435.86 M | -2.56 | 265 | $78.12 M |
FATE
|
Fate Therapeutics, Inc. | $2.32 | $418.90 M | -1.92 | 181 | $63.53 M |
NTLA
|
Intellia Therapeutics, Inc. | $14.39 | $2.19 B | -4.23 | 526 | $36.28 M |
PRME
|
Prime Medicine, Inc. | $3.14 | $788.60 M | -3.01 | 234 | $0 |
SANA
|
Sana Biotechnology, Inc. | $2.67 | $1.55 B | -4.59 | 328 | $0 |
VERV
|
Verve Therapeutics, Inc. | $4.79 | $409.24 M | -1.82 | 255 | $11.76 M |
VRTX
|
Vertex Pharmaceuticals Incorporated | $452.44 | $124.65 B | 31.39 | 5400 | $9.87 B |